Posted on
April 30, 2021 by dmartignetti
LD 675 (Sponsored By Troy Jackson) An Act To Protect Maine Consumers from Unsupported Price Increases on Prescription Medicines by Creating an Independent Review Process.
Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America
The US is easing prescription conditions for opioid treatment with New Drugs
The U.S. is reducing the possibility of reducing buprenorphine, a drug that contributes to opioid craving by recording overdose deaths.
U.S. Department of Health and Human Services announces new regulations to make it easier to prescribe medications that cure those who persist opioid dependence.
The guidelines announced on Tuesday mean that doctors and other health care workers will not need more hours of training to prescribe buprenorphine, a golden drug that helps with desire. And they no longer have to refer patients to counseling services.
Regina LaBelle, senior director of the Office of National Drug Control Policy, said in a press conference that the U.S. sees a record number of overdose deaths “most deaths this year dose over opioids, especially illegally manufactured fentanyl ”.
Joe Raedle/Getty Images
toggle caption Joe Raedle/Getty Images
The Biden administration aims to make buprenorphine, a drug proven to help people with opioid addiction, more available. Joe Raedle/Getty Images
The Biden administration says new federal guidelines released Tuesday will allow far more medical practitioners to prescribe buprenorphine, a drug proven to reduce opioid relapses and overdose deaths.
The change lowers regulatory hurdles that critics believe sharply limit use of the life-saving medication at a time when drug deaths are surging. We have made this much easier for physicians but also for other medical practitioners, said Dr. Rachel Levine, assistant secretary of health, speaking with NPR.
KUOW - As Opioid Deaths Surge, Biden Team Moves To Make Buprenorphine Treatment Mainstream kuow.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kuow.org Daily Mail and Mail on Sunday newspapers.